Sight Sciences Inc
NASDAQ:SGHT
Sight Sciences Inc
Revenue
Sight Sciences Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sight Sciences Inc
NASDAQ:SGHT
|
Revenue
$81.1m
|
CAGR 3-Years
43%
|
CAGR 5-Years
61%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Sight Sciences Inc
Revenue Breakdown
Breakdown by Geography
Sight Sciences Inc
Breakdown by Segments
Sight Sciences Inc
Total Revenue:
81.1m
USD
|
Surgical Glaucoma:
74.3m
USD
|
Dry Eye:
6.7m
USD
|
See Also
What is Sight Sciences Inc's Revenue?
Revenue
81.1m
USD
Based on the financial report for Dec 31, 2023, Sight Sciences Inc's Revenue amounts to 81.1m USD.
What is Sight Sciences Inc's Revenue growth rate?
Revenue CAGR 5Y
61%
Over the last year, the Revenue growth was 14%. The average annual Revenue growth rates for Sight Sciences Inc have been 43% over the past three years , 61% over the past five years .